Jireh Medical Imp S.A.C.
Business Opportunity Assessment Report

Company Snapshot

Jireh Medical Imp S.A.C. is a Peruvian import-distribution entity specializing in medical devices, operating under Peru’s regulatory framework for health product importers. Its core business is the procurement and domestic distribution of diagnostic and therapeutic medical equipment, functioning primarily as a distributor (not manufacturer or brand owner). Structurally, it relies overwhelmingly on German suppliers—especially Herman Medizintechnik—and concentrates 90.9% of its imports under HS code 9018909000 (other electro-medical apparatus). A notable shift occurred in early 2024: after minimal activity in Jan 2024 (4 transactions), monthly transaction volume surged to over 4,800 in Feb–Mar 2024, indicating rapid operational scaling or market entry acceleration.

Company Attribute Information

Trade Trend Analysis

Data解读: Transaction volume exhibits high volatility but strong upward momentum — from just 300 units in Jan 2024 to peaks exceeding 5,000 units in Feb–Mar 2024 and sustained >2,000-unit monthly volumes since mid-2024. Over 70% of all transactions occurred in the last 12 months, confirming active expansion. The sharp drop in May 2026 (1,118 units vs. 3,414 in Apr) suggests seasonal adjustment or supply chain recalibration rather than decline. This pattern signals active capacity building and potential consolidation of sourcing channels.

Trade Partner Analysis

Data解读: Herman Medizintechnik (Germany) dominates with 95.7% of all transactions — an extreme concentration indicating deep, long-term reliance on a single supplier. All other partners represent <5% combined and are largely inactive (‘lost’ status), suggesting limited diversification and high dependency risk. The sole active non-German partner (“No disponible”) is domestic (Peru), but contributes only 3.1% of volume and lacks transparency in identity or product scope. This reflects a tightly controlled, low-diversification procurement model vulnerable to single-supplier disruptions.

HS Code Analysis

Data解读: HS 9018909000 accounts for 90.9% of all transactions — a near-monopoly in product classification — confirming focus on ‘other electro-medical apparatus’, including disposable sensors, transducer accessories, and diagnostic interface components. Secondary codes (e.g., 9018390090, 9018190000) relate to endoscopes and ophthalmic instruments, indicating niche expansion into adjacent modalities. Most secondary codes show ‘maintained’ status, suggesting stable demand across subcategories. This extreme product focus signals specialization but also limits resilience against regulatory or tariff shifts affecting HS 901890.

Trade Region Analysis

Data解读: Germany accounts for 46.2% of transaction count — the dominant origin — closely followed by Costa Rica (42.99%), though Costa Rican trade ceased after Nov 2024. This implies recent strategic pivot away from Central American sourcing toward European (especially German) supply chains. Switzerland, France, and the U.S. show low but active engagement, while China and Brazil maintain minimal but persistent presence — likely for auxiliary components or backup sourcing. Geographic consolidation toward Germany increases efficiency but reduces regional hedging capability.

Export Port Analysis

Data解读: Frankfurt/Main (46.05%) anchors the logistics network, reflecting heavy reliance on Germany-based air cargo infrastructure. Miami (12.42%) and Stuttgart (12.42%) signal dual-track access — transatlantic re-export and direct EU distribution. The emergence of Munchen, Pusan, and La Ciotat as ‘new’ ports since 2025 indicates deliberate geographic diversification in shipping lanes — possibly to mitigate congestion or optimize Incoterms. Notably, no Peruvian port appears, confirming Jireh Medical Imp S.A.C. acts solely as importer, not exporter. Port strategy prioritizes speed and EU integration over cost optimization or multi-regional redundancy.

Contact Information

• Official Website: Not publicly available (no active domain found for jireh medical imp s.a.c.; distinct from US/HK/Singapore entities bearing similar names)
• LinkedIn: No verified profile identified
• Email / Phone / Address: Not disclosed in public registries or customs data; Peruvian S.A.C. filings do not mandate full public disclosure
• Regulatory Note: Registered as Sociedad Anónima Cerrada (S.A.C.) — a private Peruvian corporate structure with limited public financial or contact transparency

Company Trade Summary

• Dominated by one supplier (Herman Medizintechnik, Germany) and one HS code (9018909000), indicating high specialization and low diversification.
• Strong growth trajectory since early 2024, with transaction volume surging over 15× from Jan to Feb 2024.
• Strategic shift from Costa Rica to Germany as primary source region — aligning with EU regulatory alignment and quality assurance priorities.
• Logistics centered on Frankfurt/Main, with emerging nodes in Stuttgart, Munchen, and Pusan — signaling proactive route diversification.
• No evidence of local manufacturing, branding, or export activity — pure import-distribution model serving Peruvian healthcare providers.

References

• Jireh Medical, LLC Company Overview, Contact Details & Competitors | LeadIQ
• JIREH INTERNATIONAL HEALTH LIMITED Company Profile | Dun & Bradstreet
• Jireh Industries - Crunchbase Company Profile & Funding
• JIREH - Industry-leading scanners for every UT application. | LinkedIn
• Jireh International Health - Crunchbase Company Profile & Funding